Results 21 to 30 of about 19,375 (225)
Specific Histologic Type of Leiomyoma Related to Estrogen Receptor Expression
WMJ (Warmadewa Medical Journal), 2022 Uterine Leiomyoma or fibroid is the most common gynecologic benign neoplasm which arising from monoclonal proliferation of smooth muscle cells in uterine wall.
Ni Wayan Armerinayanti +2 more
doaj +1 more source
Uterine leiomyoma research [PDF]
Kosin Medical Journal, 2015 Uterine leiomyoma is the most common type of benign tumor in women of reproductive age. This disease is rare before menarche, and its incidence decreases after menopause.
Tae Hee Kim, Hae Hyeog Lee
doaj +1 more source
Рrediction of infertility in patients with uterine leiomyoma
RUDN Journal of Medicine, 2022 Infertility is an important socio-economic problem due to the fact that planned childbearing occurs much later than three decades ago. In recent years, more attention has been paid to the role of uterine leiomyoma in the development of infertility ...
Said M. Semyatov, Lemin M. Leffad
doaj +1 more source
Current Issues in Molecular Biology, 2021 Uterine leiomyoma, also known as fibroids, is the most common benign neoplasm of the female genital tract. Leiomyoma is the most common uterine tumor. The leiomyoma subtypes account for approximately 10% of leiomyomas.
Saya Tamura +5 more
doaj +1 more source
Research progress on fumarate hydratase-deficient unterine leiomyoma [PDF]
Xin yixue, 2022 Fumarate hydratase （FH）-deficient uterine leiomyoma is a rare pathological type of uterine leiomyoma, which is caused by FH gene germ-line or system mutations, primarily the latter cause. Although this disease is rare, when it is a sentinel manifestation
Wang Qing, Zheng Jingying, Ding Lianying, Zhao Weixin, Wang Mengqi, Zhao Shuhua
doaj +1 more source
Biomarkers in uterine leiomyoma [PDF]
Fertility and Sterility, 2013 Biomarkers are biologic compounds that are easily accessible and reflect normal physiology or pathology. They are useful in a variety of clinical situations that involve detection of subclinical disease, risk stratification, preoperative planning, and monitoring treatment.
Gary, Levy +4 more
openaire +2 more sources
Effects of the selective progesterone receptor modulator asoprisnil on uterine artery blood flow, ovarian activity, and clinical symptoms in patients with uterine leiomyomata scheduled for hysterectomy [PDF]
, 2008 Introduction: Asoprisnil, a novel orally active selective progesterone receptor modulator, is being studied for the management of symptomatic uterine leiomyomata. The exact mechanism of action is not yet discerned.
Williams, A.R.W. +21 more
core +1 more source
Analysis of Epithelial Growth Factor-Receptor (EGFR) Phosphorylation in Uterine Smooth Muscle Tumors [PDF]
, 2013 Uterine fibroids are the commonest uterine benign tumors. A potential mechanism of malignant transformation from leiomyomas to leiomyosarcomas has beendescribed.
Darius Dian +17 more
core +1 more source
Journal of Mid-Life Health, 2021 Objective: The objective of this study is to evaluate the effect of Vitamin D3 on symptoms, uterine and leiomyoma volume in women with symptomatic leiomyoma and hypovitaminosis D.
Amita Suneja +5 more
doaj +1 more source
Advances in the management of uterine fibroids [PDF]
, 2009 Uterine fibroids are extremely common, with major surgery the current main management option; uterine artery embolisation is an alternative, but risks to fertility are unclear.
Munro, Kirsty I, Critchley, Hilary Od
core +1 more source